UK launch for first eosinophilic oesophagitis drug
Dr Falk Pharma has launched Jorveza – the first globally licensed drug approved for eosinophilic oesophagitis – across the UK.
Read More
Tag: Dr Falk Pharma
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
